This physiotherapy device “Electronic “Mustard Plaster”” is one of the first nearly completed R&D projects of our company, which has now been brought up to the level of a workable final prototype. In this device, the active physical factor providing the therapeutic effect is heat. Heat is created on the skin surface due to the direct contact of the skin with a heating element of the device, made on a fabric basis of carbon fibers, as well as in the volume of the body area under the “plaster” due to the action of infrared (IR) radiation with a wavelength of 850 nm penetrating into tissues. Scientific results on the study of the effect of therapeutic (low-intensity) laser radiation on blood microcirculation in the irradiated zone showed that a change in a blood microcirculation (the main therapeutic effect in the low-intensity laser therapy) occurs only when tissues are heated up (see articles in the Russian journal “Doctor” No. 7, 2015, p. 18-23 and No. 8, 2015, p. 16-23). Accordingly, the required heating powers and temperatures were studied to achieve the most pronounced effect. It took about 5 years. Today the idea of physiotherapeutic treatment with both local surface and volumetric heating is implemented in this device. Patent for invention of the Russian Federation No. 2785254 with priority dated 06/02/2021 for the design of heaters was obtained. The patent for the utility model No. 232822 with the priority of 11.11.2024 “Electronic heating pad” was obtained, as well. The article “Medical and physical substantiation of exposure parameters and design of a prototype physiotherapy device for dry heat treatment” was published in 2025 in the journal “Physical Fundamentals of Instrumentation” (vol. 14, No. 1, pp. 67-77).

The device, in terms of its functional medical purpose, is an analogue of the ALMAG series devices manufactured by JSC “Elatomsky Instrument Plant”. “Electronic mustard plaster”, as well as devices of the ALMAG series, can be used for diseases of the musculoskeletal system (arthritis, arthrosis of various joints), chronic nonspecific lung diseases (chronic bronchitis, chronic pneumonia, etc.), vascular complications of diabetes (angiopathy of the lower extremities, diabetic foot) and many other degenerative-dystrophic diseases.

Today our company, together with our industrial partner LLC “PRACTIC-M”, is initiating a project for the final stage of R&D, state acceptance testing, certification and registration of the device by Roszdravnadzor. Options for financing the project are being sought.